These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
586 related articles for article (PubMed ID: 32710966)
21. Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease. Liu X; Liu S; Tang Y; Pu Z; Xiao H; Gao J; Yin Q; Jia Y; Bai Q Neurochem Res; 2021 Jun; 46(6):1514-1539. PubMed ID: 33719004 [TBL] [Abstract][Full Text] [Related]
22. Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson's disease. Jang JH; Yeom MJ; Ahn S; Oh JY; Ji S; Kim TH; Park HJ Brain Behav Immun; 2020 Oct; 89():641-655. PubMed ID: 32827699 [TBL] [Abstract][Full Text] [Related]
23. Novel fatty acid-binding protein 3 ligand inhibits dopaminergic neuronal death and improves motor and cognitive impairments in Parkinson's disease model mice. Haga H; Yamada R; Izumi H; Shinoda Y; Kawahata I; Miyachi H; Fukunaga K Pharmacol Biochem Behav; 2020 Apr; 191():172891. PubMed ID: 32126223 [TBL] [Abstract][Full Text] [Related]
24. Gutting the brain of inflammation: A key role of gut microbiome in human umbilical cord blood plasma therapy in Parkinson's disease model. Lee JY; Tuazon JP; Ehrhart J; Sanberg PR; Borlongan CV J Cell Mol Med; 2019 Aug; 23(8):5466-5474. PubMed ID: 31148353 [TBL] [Abstract][Full Text] [Related]
25. N-acetyl-L-leucine protects MPTP-treated Parkinson's disease mouse models by suppressing Desulfobacterota via the gut-brain axis. Xu Z; Lian C; Pan L; Lai W; Zhang F; Peng L; Zhou S; Zhao G; Yang X; Zhang G; Tan Z; Wang Y Brain Res Bull; 2023 Oct; 202():110729. PubMed ID: 37579888 [TBL] [Abstract][Full Text] [Related]
26. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease. Cui C; Han Y; Li H; Yu H; Zhang B; Li G Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698 [TBL] [Abstract][Full Text] [Related]
27. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease. Campos-Acuña J; Elgueta D; Pacheco R Front Immunol; 2019; 10():239. PubMed ID: 30828335 [TBL] [Abstract][Full Text] [Related]
29. The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy. Li Z; Zhang F; Sun M; Liu J; Zhao L; Liu S; Li S; Wang B PeerJ; 2023; 11():e15122. PubMed ID: 37009158 [TBL] [Abstract][Full Text] [Related]
30. Oral Trehalose Intake Modulates the Microbiota-Gut-Brain Axis and Is Neuroprotective in a Synucleinopathy Mouse Model. Pradeloux S; Coulombe K; Ouamba AJK; Isenbrandt A; Calon F; Roy D; Soulet D Nutrients; 2024 Sep; 16(19):. PubMed ID: 39408276 [TBL] [Abstract][Full Text] [Related]
31. Effects of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide on blood-brain barrier and dopaminergic neurons of rats with lipopolysaccharide-induced Parkinson's disease. Wu XL; Wang P; Liu YH; Xue YX J Mol Neurosci; 2014 May; 53(1):1-9. PubMed ID: 24254220 [TBL] [Abstract][Full Text] [Related]
32. Microbiota-mediated effects of Parkinson's disease medications on Parkinsonian non-motor symptoms in male transgenic mice. Radisavljevic N; Metcalfe-Roach A; Cirstea M; Tabusi MM; Bozorgmehr T; Bar-Yoseph H; Finlay BB mSphere; 2024 Jan; 9(1):e0037923. PubMed ID: 38078745 [TBL] [Abstract][Full Text] [Related]
34. Fecal microbiota from patients with Parkinson's disease intensifies inflammation and neurodegeneration in A53T mice. Yang H; Shao Y; Hu Y; Qian J; Wang P; Tian L; Ni Y; Li S; Al-Nusaif M; Liu C; Le W CNS Neurosci Ther; 2024 Aug; 30(8):e70003. PubMed ID: 39161161 [TBL] [Abstract][Full Text] [Related]
35. 27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction. Wang Y; An Y; Ma W; Yu H; Lu Y; Zhang X; Wang Y; Liu W; Wang T; Xiao R J Neuroinflammation; 2020 Jun; 17(1):199. PubMed ID: 32593306 [TBL] [Abstract][Full Text] [Related]
36. Allantoin ameliorates dopaminergic neuronal damage in MPTP-induced Parkinson's disease mice Yang S; Sun X; Liu D; Zhang Y; Gao X; He J; Cui M; Fu S; He D Food Funct; 2024 Sep; 15(18):9390-9408. PubMed ID: 39189380 [TBL] [Abstract][Full Text] [Related]
37. Curcumin alleviates 1-methyl- 4-phenyl- 1,2,3,6-tetrahydropyridine- induced Parkinson's disease in mice via modulating gut microbiota and short-chain fatty acids. Cai B; Zhong L; Wang Q; Xu W; Li X; Chen T Front Pharmacol; 2023; 14():1198335. PubMed ID: 37388445 [No Abstract] [Full Text] [Related]
38. Gan QX; Peng MY; Wei HB; Chen LL; Chen XY; Li ZH; An GQ; Ma YT Food Funct; 2024 Mar; 15(6):2920-2938. PubMed ID: 38385354 [TBL] [Abstract][Full Text] [Related]
39. Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson's Disease Mice via Gut Microbiota and Metabolites. Zhou ZL; Jia XB; Sun MF; Zhu YL; Qiao CM; Zhang BP; Zhao LP; Yang Q; Cui C; Chen X; Shen YQ Neurotherapeutics; 2019 Jul; 16(3):741-760. PubMed ID: 30815845 [TBL] [Abstract][Full Text] [Related]
40. Chlorogenic acid improves the cognitive deficits of sleep-deprived mice via regulation of immunity function and intestinal flora. Zhu H; Shen F; Wang X; Qian H; Liu Y Phytomedicine; 2024 Jan; 123():155194. PubMed ID: 37995532 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]